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Abstract 
 
 Clinical trials of boron neutron capture therapy (BNCT) for recurrent breast cancers are being 
considered at Japan Research Reactor No.4 (JRR-4). In this study, the irradiation technique for a total 
mastectomy patient with recurrent cancer was optimized by dosimetric calculations using JAEA 
computational dosimetry system (JCDS). The evaluation was performed using an en face technique and 
a tangents technique with thermal neutron beam mode at JRR-4. The results revealed that equivalent 
doses of lung, heart, liver and skin were similar in each irradiation technique due to the isotropic 
scattering of thermal neutrons in the body. On the other hand, the irradiation time with the tangents 
technique was a few times longer than with the en face technique. We concluded that the en face 
technique was an optimal irradiation technique for recurrent breast cancers using thermal neutron beam 
mode in terms of shorter irradiation time and easier patient positioning. 
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1. Introduction 
 Clinical trials for BNCT have been performed at JRR-4 (Nakagawa et al., 2003, Yamamoto et al., 
2009). Current BNCT trials at JRR-4 are applied for malignant brain tumor, head and neck cancer, skin 
cancer. Recurrent breast cancers are being considered as a new application of BNCT trials at JRR-4. 
Breast cancers might recur on local sites or on distant sites from the breast after primary resection. Other 
radiation therapies are conducted to treat patients of recurrent breast cancers. If sufficient boron 
compounds can be accumulated to the tumor, BNCT trials can be applied to these patients (Yanagie et al., 
2009). 
 In this study, optimal irradiation techniques for recurrent breast cancers were investigated using the 
JRR-4 neutron beam facility. A thorax model was created as a patient of total mastectomy breast with 
cancers by using the computed tomography (CT) images. We studied the preliminary dosimetry for this 
actual patient model by JCDS which was a treatment planning system developed by JAEA (Kumada et 
al., 2007). To investigate the effectiveness of different irradiation techniques, the evaluation was 
performed using en face technique and tangents technique with thermal neutron beam mode at JRR-4. 
With external photon beam radiation, the tangents technique is generally used for breast and chest wall 
treatment to reduce healthy organ doses. 
 
2. Materials and Methods 
2.1 Calculation model 
 The attempt for optimizing the irradiation technique for patients with recurrent breast cancer was 
performed using an actual thorax model by the treatment planning system JCDS. The model of the 
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recurrent breast cancer patient was created by using the CT images. The model consisted of the soft 
tissues, the bone, the skin, the lungs, the heart and the liver shown in Figure 1. The recurrent tumor was 
a simulated tumor located in the left side of the thorax surface after surgical resection treated as total 
mastectomy breast. The tumor was about 100 mm in diameter and thickness was 5 mm. The regions of 
interest (ROI) were placed on the tumor, the skin, the right lung, the left lung, the heart and the liver in 
this model. The ROI of the skin was located on the body surface including the tumor surface area. The 
materials were defined according to ICRU report 46 (1992). 
 
2.2 Overview of JCDS 
 We applied JCDS to perform the neutron and photon dosimetry in this study. JCDS is a dose 
planning system which is developed to carry out the BNCT trials based on accurate dosimetry (Kumada 
et al., 2007). To simulate the irradiations, JCDS constructs a three-dimensional model of the thorax 
based on CT images. By using CT images, organs in the thorax model such as the soft tissues and the 
bone are automatically differentiated based on CT values. JCDS creates a voxel model of the thorax 
consisting of 5×5×7 mm3 voxel cells to perform the particles transport calculation with MCNP 
efficiently. MCNP is a general purpose Monte-Carlo n-particle transport code (Briesmeister, 2000). 
 
2.3 Assumption for treatment planning 
 The concentration of 10B in the blood was assumed 24 μg/g. Tumor-blood ratio and skin-blood 
ration of boron concentration was 3.0 and 1.2, respectively. These parameters were approximately same 
as our current treatment protocol for head and neck cancers which uses para-boronophenylalanine (BPA). 
The other parameters in this study were summarized in Table 1. The compound biologic effectiveness 
(CBE) factors of skin, lung and liver were assumed 2.5, 2.3 and 4.25, respectively (Fukuda et al., 1994, 
Kiger et al., 2008, Suzuki et al., 2000). The relative biologic effectiveness (RBE) factors of 1H(n, n’)p 
reaction (fast neutron dose) and 14N(n, p)14C reaction (nitrogen dose) were assumed to be the value of 
2.5. The RBE factor of gamma ray dose was assumed to be 1.0. The CBE factors and the RBE factors 
were used to convert physical dose (Gy) to photon equivalent dose (Gy-Eq). 
 To optimize the irradiation technique for recurrent breast cancer, we evaluated the effectiveness as 
reducing the neighbor healthy organs doses with a single field technique and a multiple field technique. 
The multiple field technique, which was performed by a double-fields irradiation of tangents technique, 
was compared with a single-field irradiation of en face technique. Figure 2 shows the irradiation position 
of MCNP calculation. The en face technique was planned to homogeneously deliver the neutron beam to 
whole tumor region. The tangents technique was planned from lateral and medial tangent field with 
oblique angle of 60 degrees to the en face position. To compare the dose distributions and irradiation 
time between each irradiation technique, these treatment plans were normalized by the minimum 
equivalent dose of tumor at 30 Gy-Eq. We performed the dosimetry using these assumptions with 
thermal neutron beams of JRR-4 (JRR4-TNB2). JRR4-TNB2 was an optimal beam mode for a tumor 
spread on the breast surface because of low epithermal and fast neutrons contamination at beam aperture 
(Torii et al., 2000). 
 
3. Results and discussion 
 Table 2 summarizes the equivalent doses for the tumor and healthy organs by the en face technique 
and the tangents technique. To compare the equivalent dose of the tumor and healthy organs in each 
irradiation technique, these treatment plans were normalized by the minimum equivalent dose of tumor 
at 30 Gy-Eq. The single-field irradiation delivered 65.0 Gy-Eq as a maximum tumor dose, 18.2 Gy-Eq 
as maximum skin dose, 9.8 Gy-Eq as a maximum left lung dose, 3.7 Gy-Eq as a maximum heart dose, 
3 
 
2.0 Gy-Eq as a maximum liver dose. 
 The tangents technique was performed as irradiations from two directions which were merged 
lateral tangent and medial tangent. The total equivalent dose of the tangents technique delivered 66.8 
Gy-Eq as a maximum tumor dose, 19.5 Gy-Eq as a maximum skin dose, 8.3 Gy-Eq as a maximum left 
lung dose, 3.4 Gy-Eq as a maximum heart dose and 2.1 Gy-Eq as a maximum liver dose. The tangents 
technique provided comparable results on the tumor dose to the en face technique and delivered a 
slightly reduced maximum dose on the lung and the heart. On the other hand, the tangents technique 
delivered slightly higher skin dose than the en face technique. The mean doses and minimum doses of 
healthy organs (lung, heart, liver) were almost same doses in each irradiation technique. The irradiation 
time was 40.2 min and 118.7 min by the en face technique and by the tangents technique, respectively. 
The tangents technique was not suitable as our treatment technique for recurrent breast cancer due to the 
long irradiation time (~ 2 h). 
 Figure 3 shows equivalent dose distributions calculated for lung tissue with the en face technique 
(Figure 3a) and with the tangents technique (Figure 3b) on the thorax cross section. The isodose 
distribution with the tangents technique was merged the lateral tangent (Figure 3c) and the medial 
tangent (Figure 3d) by using merger option of JCDS. The isodose distribution of the tangents technique 
was similar to the dose distribution of the en face technique, particularly in deeper region of the body. 
The results revealed that the equivalent dose of the lung was similar in each irradiation technique due to 
the isotropic scattering of thermal neutrons in the body. 
 Our assumption of boron concentration in the tumor has not been elucidated yet. It is important for 
accurate dosimetry to understand the boron concentration of the tumor by pharmacokinetics method 
such as 18F-BPA-PET technology. If sufficient boron compound can be accumulated to breast tumors, 
the BNCT trials can be applied to the recurrent breast cancers. Furthermore, to evaluate accurate 
dosimetry for patients suffering from recurrent breast cancer, we will investigate the respiratory motion 
of patient and introduce this motion effect to our preliminary dosimetry.  
 
4. Conclusions 
 This study showed the optimal irradiation technique for BNCT dosimetry of recurrent breast 
cancers. The en face technique with thermal neutron beam was optimal technique due to shorter 
irradiation time and easier positioning of patient. The tangents technique was an advantage of maximum 
tumor, lung and heart dose over the en face technique. But, longer irradiation time was not suitable for 
actual clinical trials. We are performing further investigations with different patient models and 
techniques for recurrent breast cancers. 
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Figure 1 Cross section of evaluation model for the recurrent breast cancer. 
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Figure 2 Irradiation setting model. (a) En face technique, (b) Tangents technique. 
 
 
 
Figure 3 Comparison of isodose distributions of lung. (a) En face technique, (b) Tangents technique, (c) 
Lateral tangent field, (d) Medial tangent field. 
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Table 1 CBE factor, RBE factors and boron concentrations for this evaluation. 
  Tumor Skin Lung Liver Heart 
Boron 
concentration 
(μg/g) 
72 28.8 24 24 24 
CBE 
Boron 
dose 
3.8 2.5 2.3 4.25 1.35 
RBE  
Fast 
neutron 
dose 
2.5 
Nitrogen 
dose 
2.5 
Gamma 
dose 
1.0  
 
 
Table 2 Equivalent dose for the tumor and healthy organs and irradiation time. 
Irradiation technique En face Tangents 
Irradiation time 40.2 min 118.7 min 
Tumor Dose 
(Gy-Eq) 
Dmax 65.0  66.8  
Dmean 54.6  50.1  
Dmin 30.0  30.0  
Skin Dose 
(Gy-Eq) 
Dmax 18.2  19.5  
Left Lung 
Dose 
(Gy-Eq) 
Dmax 9.8  8.3  
Dmean 1.8  1.8  
Dmin 0.2  0.3  
Heart Dose 
(Gy-Eq) 
Dmax 3.7  3.4  
Dmean 0.7  0.7  
Dmin 0.1  0.2  
Liver Dose 
(Gy-Eq) 
Dmax 2.0  2.1  
Dmean 0.2  0.2  
Dmin < 0.1 < 0.1 
 
 
